MDM2/4 amplification predicts poor response to immune checkpoint inhibitors: a pan-cancer analysis

Lignende værker

• Reporting of Immune Checkpoint Inhibitor Therapy–Associated Diabetes, 2015–2019
  af: Liu, Jiaqing, et al.
  Udgivet: (2020)
• Ongoing Phase I Studies of Immune Checkpoint Inhibitors in China
  af: Fang, Wenfeng, et al.
  Udgivet: (2019)
• PBRM1 mutation and preliminary response to immune checkpoint blockade treatment in non-small cell lung cancer
  af: Zhou, Huaqiang, et al.
  Udgivet: (2020)
• Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment
  af: Jiang, Tao, et al.
  Udgivet: (2020)
• Research progress in immune checkpoint inhibitors for lung cancer in China
  af: Gan, Jiadi, et al.
  Udgivet: (2021)